Trainings and Resources

We created this toolkit because harm reduction programs are under-resourced and need additional funding — with the U.S. reaching 100,000 overdose deaths in the first year of the pandemic there is an urgent need for the healthcare system to fund work that is designed and driven by people who use drugs across the country. 

This News Brief defines psychostimulants; explains why psychostimulant use disorder is under-addressed, particularly in rural areas; reviews the reasons why people use psychostimulants and the harms they can cause; and addresses the impact of COVID-19 on psychostimulant use.

This News Brief describes the need for harm reduction and treatment services in rural areas for people who use psychostimulants and how those services can be provided by the opioid treatment program